Injectable, cytocompatible, elastic, free radical scavenging and electroconductive hydrogel for cardiac cell encapsulation.
The injectable electroconductive hydrogels are desirable for the regenerative therapy of electroresponsive tissues like heart. With the present electroconductive hydrogels, the issues of cytotoxicity, biodegradability, and diffusion of the conductive element and poor water solubility limit their applications. Here, electroconductive injectable single component hydrogels, PANIE-P/PEGDA and PANIS-P/PEGDA, are prepared with fumarate-co-PEG-co-sebacate comacromer conjugated with non-sulfonated/sulfonated polyaniline and PEGDA. These hydrogels have maximum electrical conductivity of 0.351±0.043×10-3Scm-1 and 0.550±0.016×10-3Scm-1, which is comparable to the native myocardium. The hydrogels with 50% comacromer concentration coded as PE50P and PS50P retain 82.48% and 84.08% water on equilibrium swelling respectively. The hydrogels have required a porous surface for cell growth and proliferation. PS50P hydrogel has stiffness of 442kPa with elastic characteristics. The hydrogel is compatible with L929 fibroblast and H9c2 cardiomyoblast cells. PS50P hydrogel has better free radical scavenging property and protective effect over cells under oxidative stress. The hydrogel retains encapsulated cardiomyoblast cells with 98% viability under static long-term in vitro culture. Briefly, the PS50P hydrogel is electroconductive, free radical scavenging and mechanically suitable for cardiac regenerative therapy.